- Cost-Effectiveness Analysis of Qsymia for Weight Loss. [Journal Article]Pharmacoeconomics 2015; 33(7):699-706P
- CONCLUSIONS: Although base-case results suggest that Qsymia is cost-effective, this result hinges on the time on Qsymia and the extent to which benefits are maintained post medication cessation. This should be an area of future research.
- Phentermine/topiramate for the treatment of obesity. [Review]Ann Pharmacother 2013; 47(3):340-9AP
- CONCLUSIONS: PHEN/TPM is a new, once-daily, controlled-release, combination weight-loss product approved as an adjunct to diet and exercise for chronic weight management of obese or overweight patients with weight-related comorbidities. PHEN/TPM is modestly effective and a viable option for patients interested in losing weight, although long-term safety data are lacking.